While transition-metal catalysts have shown the ability to regulate the Markovnikov or anti-Markovnikov regioselective hydrosilylation of aryl alkenes, the selective control of anti-Markovnikov hydrosilylation of aryl alkenes is still a huge challenge in rare-earth catalyst systems. In this study, we report the rare-earth-catalyzed regiodivergent hydrosilylation of aryl alkenes. Specifically, we achieved the highly regioselective anti-Markovnikov hydrosilylation of aryl alkenes with a scandium alkyl complex Cp*AmtBuScCH2SiMe3 (Cp* = pentamethylcyclopentadienyl, AmtBu = tBuNC(Me)NtBu, tBu = t-butyl) as a catalyst. Two key intermediates, e.g., the scandium hydride and scandium phenethyl complex for anti-Markovnikov hydrosilylation, were characterized. Guided by density functional theory (DFT) calculations, we successfully achieved the selective inversion of aryl alkenes in Markovnikov hydrosilylation using a neodymium halide complex [Cp*AmiPrNdCl]2 (AmiPr = iPrNC(Me)NiPr, iPr = isopropyl) with the larger ion radius and reduced steric hindrance in conjunction with LiCH2SiMe3. Interestingly, our study has demonstrated the significant influence of gradually increasing rare-earth ion radii on controlling the increasing Markovnikov selectivity of hydrosilylation reactions, possibly due to the enlargement of the coordination space around rare-earth metal ions. Furthermore, through a comparison of computational and experimental data, we have observed a high level of consistency, reaffirming the potential of using calculations to predict experimental outcomes and providing researchers with valuable insights.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: